Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism - Veeger, NJ; Piersma-Wichers, M; Tijssen, JG (Br J Haematol, 2005)
et al.